AIF1 and breast carcinoma: In humans, AIF-1L is involved in inflammation responses triggered by pathogenic infection or tissue injury, and increased AIF1 expression has been linked to several diseases, including endometriosis, breast cancer, atherosclerosis, rheumatoid arthritis and fibrosis (review by [92]).